Phase I Study for Safety and Efficacy of P276-00 in Subjects With Myeloma

This study has been withdrawn prior to enrollment.

(Not to expose the patients to subtherapeutic dose)

Sponsor:

Information provided by:

Piramal Enterprises Limited

ClinicalTrials.gov Identifier:

NCT00547404

First received: October 19, 2007

Last updated: April 21, 2009

Last verified: April 2009

No Study Results Posted on ClinicalTrials.gov for this Study

Study was withdrawn before participants were enrolled.

Study Status:	This study has been withdrawn prior to enrollment.
Estimated Study Completion Date:	July 2010
Estimated Primary Completion Date:	December 2009 (Final data collection date for primary outcome measure)